Article Text

Download PDFPDF
New UK guidelines for the management of adult patients with ARDS

Statistics from


  • Funding MG reports grants, personal fees and non-financial support from GSK, personal fees from BI, personal fees from Silence therapeutics, personal fees from Cell catapult, outside the submitted work. EF reports personal fees from MC3 Cardiopulmonary, personal fees from ALung Technologies, outside the submitted work.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.